Tenet Healthcare price target raised to $89 from $87 at Stephens

Stephens analyst Scott Fidel raised the firm’s price target on Tenet Healthcare to $89 from $87 and keeps an Equal Weight rating on the shares. Positive Q2 performance reflected the company’s high exposure to rising outpatient elective procedures, though the second half outlook assumes somewhat more moderate volume growth compared to the Q2 trends, the analyst tells investors in a research note.